de La Fuente-Fernández R - Search Results

1

Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition.

de La Fuente-Fernández R, Lim AS, Sossi V, Holden JE, Calne DB, Ruth TJ, Stoessl AJ. de La Fuente-Fernández R, et al. J Cereb Blood Flow Metab. 2001 Oct;21(10):1151-9. doi: 10.1097/00004647-200110000-00003. J Cereb Blood Flow Metab. 2001. PMID: 11598492

2

Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data.

Sossi V, de La Fuente-Fernández R, Holden JE, Doudet DJ, McKenzie J, Stoessl AJ, Ruth TJ. Sossi V, et al. J Cereb Blood Flow Metab. 2002 Feb;22(2):232-9. doi: 10.1097/00004647-200202000-00011. J Cereb Blood Flow Metab. 2002. PMID: 11823721

3

Parkinson's disease: imaging update.

de la Fuente-Fernández R, Stoessl AJ. de la Fuente-Fernández R, et al. Curr Opin Neurol. 2002 Aug;15(4):477-82. doi: 10.1097/00019052-200208000-00012. Curr Opin Neurol. 2002. PMID: 12151846 Review.

4

Dopamine release in human ventral striatum and expectation of reward.

de la Fuente-Fernández R, Phillips AG, Zamburlini M, Sossi V, Calne DB, Ruth TJ, Stoessl AJ. de la Fuente-Fernández R, et al. Behav Brain Res. 2002 Nov 15;136(2):359-63. doi: 10.1016/s0166-4328(02)00130-4. Behav Brain Res. 2002. PMID: 12429397 Clinical Trial.

5

VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.

De La Fuente-Fernández R, Furtado S, Guttman M, Furukawa Y, Lee CS, Calne DB, Ruth TJ, Stoessl AJ. De La Fuente-Fernández R, et al. Synapse. 2003 Jul;49(1):20-8. doi: 10.1002/syn.10199. Synapse. 2003. PMID: 12710012

6

Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.

de la Fuente-Fernández R, Schulzer M, Mak E, Calne DB, Stoessl AJ. de la Fuente-Fernández R, et al. Brain. 2004 Apr;127(Pt 4):888-99. doi: 10.1093/brain/awh102. Epub 2004 Feb 11. Brain. 2004. PMID: 14960500

7

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.

de la Fuente-Fernández R, Sossi V, Huang Z, Furtado S, Lu JQ, Calne DB, Ruth TJ, Stoessl AJ. de la Fuente-Fernández R, et al. Brain. 2004 Dec;127(Pt 12):2747-54. doi: 10.1093/brain/awh290. Epub 2004 Aug 25. Brain. 2004. PMID: 15329355

8

Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms.

Sossi V, de la Fuente-Fernández R, Holden JE, Schulzer M, Ruth TJ, Stoessl J. Sossi V, et al. J Cereb Blood Flow Metab. 2004 Aug;24(8):869-76. doi: 10.1097/01.WCB.0000126563.85360.75. J Cereb Blood Flow Metab. 2004. PMID: 15362717

9

Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies.

Koochesfahani KM, de la Fuente-Fernández R, Sossi V, Schulzer M, Yatham LN, Ruth TJ, Blinder S, Stoessl AJ. Koochesfahani KM, et al. Mov Disord. 2006 Jul;21(7):970-5. doi: 10.1002/mds.20857. Mov Disord. 2006. PMID: 16570297 Clinical Trial.

10

Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.

Sossi V, de la Fuente-Fernández R, Schulzer M, Troiano AR, Ruth TJ, Stoessl AJ. Sossi V, et al. Ann Neurol. 2007 Nov;62(5):468-74. doi: 10.1002/ana.21204. Ann Neurol. 2007. PMID: 17886297

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters